Letter

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option

BMJ 2005; 331 doi: 10.1136/bmj.331.7530.1474-b (Published 15 December 2005)
Cite this as: BMJ 2005;331:1474.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Michael R Lewis, general practitioner (Michael.Lewis@gp-w96010.wales.nhs.uk)1,
  2. Diana Kay, general practitioner2
  1. 1 Welshpool Medical Centre, Powys SY21 7ER
  2. 2 Cheam Family Practice, Sutton, Surrey SM1 2HD

    EDITOR—The study by Hippisley-Cox et al into the safety of cyclo-oxygenase-2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDS) is subject to more indication bias than they suggest.1

    When the study began, five years ago, COX-2 inhibitors were widely regarded …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular